The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma.
about
The role of targeted treatment in mantle cell lymphoma: is transplant dead or alive?Pretransplantation Minimal Residual Disease Predicts Survival in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission.Non-myeloablative allogeneic hematopoietic stem cell transplantation for adults with relapsed and refractory mantle cell lymphoma: a single-center analysis in the rituximab eraGene mutations and actionable genetic lesions in mantle cell lymphoma.Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.Prognosis and outcome of stem cell transplantation for mantle cell lymphoma.Treatment options for mantle cell lymphoma.Autologous stem cell transplantation (ASCT) in patients with mantle cell lymphoma: a retrospective study of the Spanish lymphoma group (GELTAMO).Reduced-intensity or myeloablative allogeneic hematopoietic cell transplantation for mantle cell lymphoma: a systematic review.Current treatment strategies in relapsed/refractory mantle cell lymphoma: where are we now?Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials.15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau.Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC.Allogeneic hematopoietic cell transplantation for lymphoma: baseline and posttransplant prognostic factors.Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy.
P2860
Q26772907-64617EC7-1FC3-4740-86CC-350BEF0E3A74Q36474029-2C09EAE3-5131-45FF-89F7-733832973C67Q37071972-0E7E128F-75F3-4DB9-B96C-4EDAF8C6F739Q37629080-2411E13E-83FF-41AA-ADA0-FF39D494265FQ38387292-76398DCA-08B0-4910-9B2A-ED6D9C90C645Q38532268-246EE619-5634-4D7F-A5FC-53106ED1F0C6Q38584922-E7A8E53B-A3A7-4C7F-B3FE-67A8AEFC2307Q38768069-16C90DB2-3F45-4356-B498-9CFE1831599CQ38844932-C5DB3E7D-9547-4B27-9127-F42D021C9619Q39044162-3ECF3F99-3AEB-4F3B-9007-D800F7DAB037Q40284895-CE25FDFC-5119-432D-9661-CB56376FB823Q40513690-DAFEDDDF-3979-4EF3-A3D3-E7A5DDA7B4EDQ40783463-A3CF82DA-9F16-4F76-9F6E-38D41BE1DED3Q48551157-C7F3A50C-D5A6-47BA-A38F-73510A58E728Q50205176-57F0E659-2849-4808-AB46-A65ABE8A9912Q55610546-63C6822B-F8C9-4D6F-89E3-AE998BD3E91C
P2860
The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The EBMT/EMCL consensus projec ...... ation in mantle cell lymphoma.
@en
type
label
The EBMT/EMCL consensus projec ...... ation in mantle cell lymphoma.
@en
prefLabel
The EBMT/EMCL consensus projec ...... ation in mantle cell lymphoma.
@en
P2093
P2860
P50
P356
P1433
P1476
The EBMT/EMCL consensus projec ...... ation in mantle cell lymphoma.
@en
P2093
D Caballero
European MCL Network and the L ...... ood and Marrow Transplantation
M Dreyling
M Ghielmini
S Le Gouill
S Robinson
P2860
P2888
P304
P356
10.1038/LEU.2014.223
P577
2014-07-18T00:00:00Z
P6179
1005464580